SLC7A5 and myelodysplastic syndrome: We also observed reciprocal cases; for example, SLC7A5 is normally down-regulated in MDS lines, and MECP2 ASO treatment restores this gene back to unaffected control levels and causes an up-regulation of SLC7A5 in MECP2 ASO-treated unaffected control lines (Fig. 5C).